{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T11:26:18Z","timestamp":1788866778584,"version":"build-2803163510"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2020,9,27]],"date-time":"2020-09-27T00:00:00Z","timestamp":1601164800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,7,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Baclofen (BLF) has been prescribed in the UK since 1972 for the alleviation of spasticity. However, evidence suggests BLF is also recreationally misused. It has been associated with ethanol, gamma-hydroxybutyric acid (GHB), pregabalin (PGL) and gabapentin (GBP) use\/abuse, and deaths have been reported. With current postmortem (PM) toxicological screening approaches, BLF is not routinely included in the general drugs screen and is only screened for if specifically mentioned in the case documents. The extent of BLF misuse is thus unclear. This study was carried out to determine the prevalence and concentrations of BLF in Coroners\u2019 toxicology, to investigate whether BLF misuse with ethanol, GHB, PGL and GBP is causing death and to determine the potential extent of the underreporting of BLF-associated deaths. Between 1 January 2016 and 31 December 2017, 3,750 PM femoral vein bloods were screened for BLF; all positive cases were quantified. Only 0.56% of samples screened positive for BLF, with concentration ranging from 0.08 to 102.00 \u00b5g\/mL (median\u2009=\u20090.28). It was determined that if routine analysis without additional screening of BLF had been performed, 43% of BLF positives cases would have been missed. However, given the low incidence of detection, this only represents 0.25% of the cohort. Likely illicit use of BLF with GHB was seen in one case only. Death from the recreational use of BLF with PGL and GBP was not observed. Only two cases positive for BLF had an ethanol concentration of\u2009\u226550 mg%. Two cases of presumed intentional overdose of BLF were observed. This study highlights that although BLF abuse may be occurring, deaths are rare. It is therefore not cost- or time-effective to screen for BLF in all PM cases. With BLF currently being investigated for the treatment of alcoholism and withdrawal symptoms of illicit drug use, BLF-related deaths may rise in the future.<\/jats:p>","DOI":"10.1093\/jat\/bkaa132","type":"journal-article","created":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T12:23:49Z","timestamp":1600345429000},"page":"612-618","source":"Crossref","is-referenced-by-count":6,"title":["Baclofen: To Screen or Not to Screen in Postmortem Blood?"],"prefix":"10.1093","volume":"45","author":[{"given":"Limon Khatun","family":"Nahar","sequence":"first","affiliation":[{"name":"Toxicology Unit, Imperial College London, Toxicology Unit, London, W6 8RP, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin G","family":"Murphy","sequence":"additional","affiliation":[{"name":"Section of Endocrinology and Investigative Medicine, Imperial College London, Endocrinology and Metabolism, London, W12 0NN, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue","family":"Paterson","sequence":"additional","affiliation":[{"name":"Toxicology Unit, Imperial College London, Toxicology Unit, London, W6 8RP, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,9,27]]},"reference":[{"key":"2021071015264214200_R1","article-title":"National Institute for Health and Care Excellence (NICE)","volume-title":"British National Formulary - Baclofen","year":"2018"},{"key":"2021071015264214200_R2","first-page":"99","article-title":"Clinical effectiveness of baclofen for the treatment of alcohol dependence: a review","volume":"5","author":"Brennan","year":"2013","journal-title":"Clinical Pharmacology"},{"key":"2021071015264214200_R3","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.pbb.2012.11.013","article-title":"A human laboratory pilot study with baclofen in alcoholic individuals","volume":"103","author":"Leggio","year":"2013","journal-title":"Pharmacology, Biochemistry, and Behavior"},{"key":"2021071015264214200_R4","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1471-4159.1979.tb04516.x","article-title":"Baclofen: Effects on amino acid release and metabolism in slices of guinea pig cerebral cortex","volume":"32","author":"Potashner","year":"1979","journal-title":"Journal of Neurochemistry"},{"key":"2021071015264214200_R5","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/bcp.12277","article-title":"Misuse of the \u03b3-aminobutyric acid analogues baclofen, gabapentin and pregabalin in the UK","volume":"78","author":"Kapil","year":"2014","journal-title":"British Journal of Clinical Pharmacology"},{"key":"2021071015264214200_R6","article-title":"Is there evidence of misuse of baclofen, gabapentin and pregabalin in the United Kingdom (UK)?","volume":"51","author":"Wood","year":"2013","journal-title":"Clinical Toxicology"},{"key":"2021071015264214200_R7","first-page":"372","article-title":"Emergency Department presentations following recreational use of baclofen, gabapentin and pregabalin: a Euro-DEN case series","volume":"53","author":"Yates","year":"2015","journal-title":"Clinical Toxicology"},{"key":"2021071015264214200_R8","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nn1181","article-title":"Bi-directional effects of GABAB receptor agonists on the mesolimbic dopamine system","volume":"7","author":"Cruz","year":"2004","journal-title":"Nature Neuroscience"},{"key":"2021071015264214200_R9","article-title":"Health & Social Care Information Centre (HSCIC)","volume-title":"Prescription Cost Analysis England 2010","year":"2011"},{"key":"2021071015264214200_R10","article-title":"National Health Service (NHS) England","volume-title":"Prescription Cost Analysis England 2018","year":"2019"},{"key":"2021071015264214200_R11","article-title":"Novartis Pharmaceuticals UK Ltd","volume-title":"Lioresal Tablets 10mg - Summary of Product Characteristics (SmPC) - (eMC)","year":"2016"},{"key":"2021071015264214200_R12","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1093\/jat\/bkv125","article-title":"Validated method for the quantification of baclofen in human plasma using solid-phase extraction and liquid chromatography\u2013tandem mass spectrometry","volume":"40","author":"Nahar","year":"2016","journal-title":"Journal of Analytical Toxicology"},{"key":"2021071015264214200_R13","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1080\/01952307.1992.11761520","article-title":"Clinical and pharmacokinetic aspects of high dose oral baclofen therapy","volume":"15","author":"Aisen","year":"1992","journal-title":"The Journal of the American Paraplegia Society"},{"key":"2021071015264214200_R14","doi-asserted-by":"crossref","DOI":"10.1038\/sj.npp.1300999","article-title":"Effects of baclofen on cocaine self-administration: opioid and nonopioid-dependent volunteers","volume":"31","author":"Haney","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"2021071015264214200_R15","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1046\/j.1365-2710.2000.00295.x","article-title":"Double-blind randomized controlled trial of baclofen vs. clonidine in the treatment of opiates withdrawal","volume":"25","author":"Akhondzadeh","year":"2000","journal-title":"Journal of Clinical Pharmacy and Therapeutics"},{"key":"2021071015264214200_R16","doi-asserted-by":"crossref","DOI":"10.1186\/s13063-016-1593-9","article-title":"Improving GHB withdrawal with baclofen: study protocol for a feasibility study for a randomised controlled trial","volume":"17","author":"Lingford-Hughes","year":"2016","journal-title":"Trials"},{"key":"2021071015264214200_R17","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1177\/0269881112444324","article-title":"BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP","volume":"26","author":"Lingford-Hughes","year":"2012","journal-title":"Journal of Psychopharmacology"},{"key":"2021071015264214200_R18","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ajp.2015.06.015","article-title":"High doses of baclofen as suicide attempt in patients with alcohol use disorders\u2013a serious concern","volume":"17","author":"Holla","year":"2015","journal-title":"Asian Journal of Psychiatry"},{"key":"2021071015264214200_R19","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/alcalc\/ags076","article-title":"A case of de novo seizures following a probable interaction of high-dose baclofen with alcohol","volume":"47","author":"Rolland","year":"2012","journal-title":"Alcohol and Alcoholism"},{"key":"2021071015264214200_R20","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S0196-0644(83)80562-9","article-title":"Baclofen overdose","volume":"12","author":"May","year":"1983","journal-title":"Annals of Emergency Medicine"},{"key":"2021071015264214200_R21","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1742-6723.2006.00805.x","article-title":"Baclofen overdose: defining the spectrum of toxicity","volume":"18","author":"Leung","year":"2006","journal-title":"Emergency Medicine Australasia"},{"key":"2021071015264214200_R22","doi-asserted-by":"publisher","first-page":"923","DOI":"10.3109\/15563650.2015.1088158","article-title":"Usefulness of plasma drug monitoring in severe baclofen poisoning","volume":"53","author":"Cleophax","year":"2015","journal-title":"Clinical Toxicology (Phila)"},{"key":"2021071015264214200_R23","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1542\/peds.101.6.1045","article-title":"Baclofen overdose: drug experimentation in a group of adolescents","volume":"101","author":"Perry","year":"1998","journal-title":"Pediatrics"},{"key":"2021071015264214200_R24","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1007\/s00431-012-1780-y","article-title":"Baclofen intoxication: a \u201cfun drug\u201d causing deep coma and nonconvulsive status epilepticus\u2014a case report and review of the literature","volume":"171","author":"Wei\u00dfhaar","year":"2012","journal-title":"European Journal of Pediatrics"},{"key":"2021071015264214200_R25","article-title":"Bluelight","volume-title":"Baclofen (Lioresal) - Miracle Drug or Crap","year":"2010"},{"key":"2021071015264214200_R26","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1097\/ADM.0000000000000084","article-title":"Baclofen and \u03b3-hydroxybutyrate (GHB), a dangerous combination","volume":"9","author":"Kamal","year":"2015","journal-title":"Journal of Addiction Medicine"},{"key":"2021071015264214200_R27","article-title":"Drugs-Forum","volume-title":"Combinations - Baclofen and Lyrica = legal ghb!","year":"2013"},{"key":"2021071015264214200_R28","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k4364","article-title":"Pregabalin and gabapentin become controlled drugs to cut deaths from misuse","volume":"363","author":"Mayor","year":"2018","journal-title":"The British Medical Journal"},{"key":"2021071015264214200_R29","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3109\/15563650.2011.654209","article-title":"Baclofen overdose mimicking brain death","volume":"50","author":"Sullivan","year":"2012","journal-title":"Clinical Toxicology"},{"key":"2021071015264214200_R30","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/15563650.2017.1284330","article-title":"Self-poisoning with baclofen in alcohol-dependent patients: national reports to French Poison Control Centers, 2008\u20132013","volume":"55","author":"Pelissier","year":"2017","journal-title":"Clinical Toxicology"},{"key":"2021071015264214200_R31","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1007\/s11419-016-0314-0","article-title":"Application of high-resolution mass spectrometry to determination of baclofen in a case of fatal intoxication","volume":"34","author":"Szpot","year":"2016","journal-title":"Forensic Toxicology"},{"key":"2021071015264214200_R32","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/S0379-0738(01)00512-6","article-title":"Death due to baclofen and dipyrone ingestion","volume":"123","author":"De Giovanni","year":"2001","journal-title":"Forensic Science International"},{"key":"2021071015264214200_R33","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1520\/JFS13182J","article-title":"Toxicological analysis of a fatal baclofen (Lioresal) ingestion","volume":"36","author":"Fraser","year":"1991","journal-title":"Journal of Forensic Science"},{"key":"2021071015264214200_R34","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jchromb.2004.10.036","article-title":"Screening and semi-quantitative analysis of post mortem blood for basic drugs using gas chromatography\/ion trap mass spectrometry","volume":"813","author":"Paterson","year":"2004","journal-title":"Journal of Chromatography B"},{"key":"2021071015264214200_R35","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1258\/0004563001899744","article-title":"Analysis of urine for drugs of abuse using mixed-mode solid-phase extraction and gas chromatography-mass spectrometry","volume":"37","author":"Paterson","year":"2000","journal-title":"Annals of Clinical Biochemistry"},{"key":"2021071015264214200_R36","volume-title":"Disposition of Toxic Drugs and Chemicals in Man","author":"Baselt","year":"2014","edition":"10th edition"},{"key":"2021071015264214200_R37","volume-title":"Clarke\u2019s Analysis of Drugs and Poisons","author":"Moffat","year":"2011","edition":"4th edition"},{"key":"2021071015264214200_R38","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.scijus.2010.09.005","article-title":"The United Kingdom and Ireland Association of Forensic Toxicologists forensic toxicology laboratory guidelines","volume":"50","author":"Cooper","year":"2010","journal-title":"Science & Justice"},{"key":"2021071015264214200_R39","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1093\/jat\/bkx019","article-title":"Validated method for the screening and quantification of baclofen, gabapentin and pregabalin in human postmortem whole blood using protein precipitation and liquid chromatography\u2013tandem mass spectrometry","volume":"41","author":"Nahar","year":"2017","journal-title":"Journal of Analytical Toxicology"},{"key":"2021071015264214200_R40","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1097\/FTD.0000000000000546","article-title":"Therapeutic drug monitoring of antiepileptic drugs in epilepsy: a 2018 update","volume":"40","author":"Patsalos","year":"2018","journal-title":"Therapeutic Drug Monitoring"},{"key":"2021071015264214200_R41","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/j.0013-9580.2004.31203.x","article-title":"Pregabalin add-on treatment: a randomized, double-blind, placebo-controlled, dose\u2013response study in adults with partial seizures","volume":"45","author":"Arroyo","year":"2004","journal-title":"Epilepsia"},{"key":"2021071015264214200_R42","first-page":"9","article-title":"The chemistry and kinetics of Lioresal","volume":"48","author":"Faigle","year":"1972","journal-title":"Postgraduate Medical Journal"},{"key":"2021071015264214200_R43","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3109\/00365518109092032","article-title":"Concentrations of baclofen in serum and breast milk from a lactating woman","volume":"41","author":"Eriksson","year":"1981","journal-title":"Scandinavian Journal of Clinical and Laboratory Investigation"},{"key":"2021071015264214200_R44","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s40263-018-0516-6","article-title":"Baclofen to prevent relapse in gamma-hydroxybutyrate (GHB)-dependent patients: a multicentre, open-label, non-randomized, controlled trial","volume":"32","author":"Beurmanjer","year":"2018","journal-title":"CNS Drugs"},{"key":"2021071015264214200_R45","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1360-0443.2010.03145.x","article-title":"Gamma-butyrolactone (GBL) dependence and withdrawal","volume":"106","author":"Bell","year":"2011","journal-title":"Addiction"}],"container-title":["Journal of Analytical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jat\/advance-article-pdf\/doi\/10.1093\/jat\/bkaa132\/33937017\/bkaa132.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jat\/article-pdf\/45\/6\/612\/38895373\/bkaa132.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jat\/article-pdf\/45\/6\/612\/38895373\/bkaa132.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T13:04:51Z","timestamp":1696683891000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jat\/article\/45\/6\/612\/5912484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,27]]},"references-count":45,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,9,27]]},"published-print":{"date-parts":[[2021,7,10]]}},"URL":"https:\/\/doi.org\/10.1093\/jat\/bkaa132","relation":{},"ISSN":["0146-4760","1945-2403"],"issn-type":[{"value":"0146-4760","type":"print"},{"value":"1945-2403","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,7,1]]},"published":{"date-parts":[[2020,9,27]]}}}